William Blair & Company
AVNS

William Blair & Company’s Avanos Medical AVNS Stock Holding History

William Blair & Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,804
Closed -$261K – 1663
2018
Q3 		$261K Sell
3,804
-475
-11% -$30.6K ﹤0.01% 1199
2018
Q2 		$245K Buy
+4,279
New +$226K ﹤0.01% 1197
2018
Q1 		– Sell
-4,896
Closed -$226K – 1516
2017
Q4 		$226K Sell
4,896
-370
-7% -$17K ﹤0.01% 1225
2017
Q3 		$237K Sell
5,266
-97
-2% -$4.14K ﹤0.01% 1198
2017
Q2 		$211K Sell
5,363
-4
-0.1% -$151 ﹤0.01% 1321
2017
Q1 		$209K Buy
+5,367
New +$209K ﹤0.01% 1206
2016
Q4 		– Sell
-6,046
Closed -$210K – 1400
2016
Q3 		$210K Sell
6,046
-1,011
-14% -$35.4K ﹤0.01% 1145
2016
Q2 		$229K Buy
+7,057
New +$216K ﹤0.01% 1080
2016
Q1 		– Sell
-6,329
Closed -$211K – 1194
2015
Q4 		$211K Buy
+6,329
New +$197K ﹤0.01% 1071
2015
Q3 		– Sell
-7,779
Closed -$315K – 1414
2015
Q2 		$315K Sell
7,779
-1,579
-17% -$70.9K ﹤0.01% 1921
2015
Q1 		$460K Sell
9,358
-2,058
-18% -$95.3K ﹤0.01% 1740
2014
Q4 		$519K Buy
+11,416
New +$449K ﹤0.01% 1680

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company's AVNS Position: Q4 2018 in Review

William Blair & Company sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,804 shares — an estimated $261K sold.

William Blair & Company first reported a position in AVNS in Q4 2014 and held it in 12 quarters. The position peaked at $519K in Q4 2014. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • William Blair & Company reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • William Blair & Company sold 3,804 Avanos Medical shares in Q4 2018, an estimated $261K.
  • William Blair & Company first reported a position in Avanos Medical in Q4 2014 and held it in 12 quarters.
  • William Blair & Company's Avanos Medical position peaked at $519K in Q4 2014.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on William Blair & Company's 13F filing for Q4 2018, filed 14 Feb 2019.